Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
RecruitingOBSERVATIONAL
Enrollment
100
Participants
Timeline
Start Date
September 10, 2024
Primary Completion Date
September 30, 2029
Study Completion Date
September 10, 2034
Conditions
Esophageal Cancer (EsC)
Trial Locations (1)
Unknown
RECRUITING
Semmelweis University, Budapest
All Listed Sponsors
lead
Semmelweis University
OTHER
NCT06713993 - Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer | Biotech Hunter | Biotech Hunter